[1] |
CHEN Jing, XUE Xiaotong, ZHU Li, LIU Hong, ZHANG Furen.
Treatment of perifolliculitis capitis abscedens et suffodiens with TNF-α inhibitors: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(5): 326-329.
|
[2] |
JIN Chuanyang, WANG Zhenzhen, SUN Lele, LIU Tingting, LIU Hong, ZHANG Furen.
Correlation between MAP3K7 and MPO genes and pyoderma gangrenosum in Chinese population
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(4): 245-249.
|
[3] |
LU Yu, JIANG Dong, YANG Dengke, HU Siyuan, YUAN Dezheng, ZHOU Xiaomei, QIN Jianping, GE Jinhong, ZHANG Fengrui, LI Wenyao, GUO Yiyu.
Adalimumab for the treatment of perifolliculitis capitis abscedens et suffodiens: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 210-211.
|
[4] |
JIAO Yuzhu, YANG Qing.
Update of treatment of pyoderma gangrenosum
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(3): 216-220.
|
[5] |
WANG Tianzi, SONG Peng, ZHANG Mingkai, CHEN Mingfei, LIU Yongxia, YANG Qing.
Pyoderma gangrenosum successfully treated with ixekizumab: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(11): 795-798.
|
[6] |
DU Baiyinzi, WANG Huiping, LUO Suju.
Efficacy and safety comparation of adalimumab and secukinumab in the treatment of nail psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2024, 40(1): 26-30.
|
[7] |
ZHENG Chunzhi, ZHANG Weilin, GUO Xiao, YANG Baoqi, YANG Qing, LIU Hong.
Efficacy and safety of ixekizumab and adalimumab in the treatment of moderate to severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(9): 633-638.
|
[8] |
LI Honghui, ZHAO Qing, YOU Jiabao, YANG Baoqi, YANG Qing, SHI Zhongxiang, LIU Hong, ZHANG Furen.
Clinical analysis of 65 patients with severe adverse drug reactions
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 332-337.
|
[9] |
SANG Xu, WANG Zhenzhen, LI Wenchao, LIU Hong, ZHANG Furen.
Cost-effectiveness analysis of biologic agents in the treatment of moderate-to-severe plaque psoriasis
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(5): 344-349.
|
[10] |
ZANG Xiao, LI Hongda, LIU Yongxia, LU Xianmei, YANG Qing, WANG Weiwei, WU Weizhi.
Pyoderma gangrenosum successfully treated with adalimumab: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2023, 39(1): 15-17.
|
[11] |
FENG Chenchen, YANG Zhuanhua, LI Gaojie, LI Wei.
Update of the diagnosis and treatment of pyoderma gangrenosum
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(6): 414-418.
|
[12] |
LI Jun, ZHANG Litao.
Skin phototoxicity induced by pirfenidone: a case report
[J]. China Journal of Leprosy and Skin Diseases, 2022, 38(4): 236-237.
|
[13] |
WANG Youlin, WANG Rui, ZHAO Zhenkai, SUN Jie, ZHANG Yuan, TANG Zijie, ZHANG Han, SHU Xin, LI Chengxin.
Efficacy of adalimumab in the treatment of plaque psoriasis with or without metabolic syndrome
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(12): 755-758.
|
[14] |
LIU Chengling, WANG Rui, ZHOU Yong.
Disseminated granuloma annulare treated with adalimumab: a case report and literature review
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(11): 706-709.
|
[15] |
ZANG Xiao, SONG Pingping, ZHU Huiying, DU Donghong, SHI Zhongxiang.
Adalimumab combined with glucocorticoid in the treatment of one pediatric case of Stevens-Johnson syndrome and review of the literature
[J]. China Journal of Leprosy and Skin Diseases, 2021, 37(11): 716-718.
|